Table 4.
Biomarkers | Targets |
---|---|
Oxidative stress | Lipid peroxidation products 4-hydroxy-2-nonenal, malondialdehyde, F2-isoprostanes |
Inflammatory responses (cytokines and prostaglandins) | NF-kappa B, Toll like receptors, NLRP3 inflammasome IL-6, IL-8, TNF-alpha |
Exosomes/Microparticles | Distinct micro-vesicles |
Innate host defense | RAGE receptors (S100A8 and S100A9) Advanced glycation end products Histone deacetylases (HDACs) |
DNA methylation/epigenetic modifications | Differential |
Proteases | Matrix metalloproteases (MMP-2, MMP-9) |
Growth factors and proliferation of cells | VEGF, FGF, fibroblast growth factor (FGF), PDGF, TGF-β |
Clinical parameters | PI, PD and CAL Pulmonary function (FEV1, FVC, and ratio) |